logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Charles Lynde

lynde dermatology and probity medical research

63H指数
413论文数
1.4W被引数
收录论文 217
发表时间
logo
Real-World Evidence of Upadacitinib in Atopic Dermatitis after Inadequate Response or Intolerance to Dupilumab: The CAN UpTIMISE Study奥马帕尼布在特应性皮炎中的应用：在双卢木单抗治疗反应不佳或耐受性差后的真实世界证据：CAN UpTIMISE研究
errDermatology and Therapy
IF4.2
err2026-09-11
err0
errOAAI
errVimal H. Prajapati; Vipul Jain; Melinda J. Gooderham; Michael Cecchini; Jason K. Lee; Charles W. Lynde; Parbeer Grewal; Andrew Ferrier; David Préfontaine; Carly Sterling; H. Chih-ho Hong
err分享
err收藏
Disease Burden in a Cohort of Canadian Adults With Moderate-to-Severe Atopic Dermatitis by Systemic Therapy Use系统性治疗使用在患有中重度特应性皮炎的加拿大成人队列中的疾病负担
errJournal of Cutaneous Medicine and Surgery
IF3.9
err2026-03-26
err0
PREAI
errMelinda J. Gooderham; Maksym Breslavets; Irina Turchin; Wei Jing Loo; Angélique Gagné-Henley; Danielle Brassard; Cristina Sancho; Shirley H. Chen; Mélanie Labelle; David Préfontaine; Charles W. Lynde
err分享
err收藏
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment Paradigms加拿大慢性手部湿疹的当前与未来管理：不断演变的治疗模式
errJournal of Cutaneous Medicine and Surgery
IF3.9
err2026-03-19
err0
PREAI
errJensen Yeung; Melinda Gooderham; H. Chih-ho Hong; Charles Lynde; Vimal H. Prajapati
err分享
err收藏
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies鲁索利替尼乳膏按需单药治疗可显著改善轻至中度特应性皮炎患者的疾病和症状控制：两项III期研究的合并分析
errDermatology and Therapy
IF4.2
err2026-02-12
err0
errOAAI
errAndrew Blauvelt; Leon Kircik; Eric L. Simpson; Peter Lio; Lawrence F. Eichenfield; Vimal H. Prajapati; Parbeer Grewal; Charles Lynde; H. Chih-ho Hong; Daniel Sturm; Howard Kallender; Haobo Ren; Dilan Paranagama; Grace K. W. Wong; Bob Geng
err分享
err收藏
Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase 3b/4 Study (LEVEL UP)在Dupilumab治疗反应不足后，成人及青少年中重度特应性皮炎患者从Dupilumab转换为Upadacitinib：来自Phase 3b/4研究（LEVEL UP）第二期试验的疗效与安全性结果
errAmerican Journal of Clinical Dermatology
IF8.8
err2026-01-14
err0
errOAAI
errChristopher G. Bunick; Nina Magnolo; Angela Moore; Masatoshi Abe; Xinghua Gao; Charles Lynde; Nadia Ibrahim; Gweneth Levy; Brian M. Calimlim; Xiaoqiang Wu; Yolanda Armendariz; Ayman Grada; Kilian Eyerich
err分享
err收藏
Efficacy and Safety of Ruxolitinib Cream Combined With Narrow-Band UVB Phototherapy for Treatment of Vitiligo鲁索利替尼乳膏联合窄谱UVB光疗治疗白癜风的疗效与安全性
errJournal of Investigative Dermatology
IF5.7
err2025-12-11
err0
PREAI
errAmit G. Pandya; Charles W. Lynde; Maryam Shayesteh Alam; Ira H. Thorla; Katherine Reed; Lawrence J. Green; Babak Soltanalizadeh; Diana Stefani-Hunyady; Deanna Kornacki; Mark S. Amster
err分享
err收藏
Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis32周、第3期DISCREET研究的结果：apremilast在患有中重度生殖器银屑病患者中的疗效
errJournal of the European Academy of Dermatology and Venereology
IF8
err2025-12-10
err0
errOAAI
errJoseph F. Merola; Lyn Guenther; Charles Lynde; Kim A. Papp; Lawrence Charles Parish; Paul Yamauchi; Sue Cheng; Hamid Amouzadeh; Cynthia Deignan; Shauna Jardon; Mindy Chen; Andreas Pinter
err分享
err收藏
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b StudyAmlitelimab STREAM-AD 二期研究的头颈部特应性皮炎与其他身体部位特应性皮炎的事后分析
errDermatology and Therapy
IF4.2
err2025-12-08
err0
errOAAI
errAdam Reich; Andrew Blauvelt; Stephan Weidinger; Vivian Y. Shi; Norito Katoh; Charles Lynde; Xinghua Gao; Nicole M. Armstrong; Charlotte Bernigaud; Kassim Rahawi
err分享
err收藏
NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin ReactionsNECOM 7：使用护肤产品预防及治疗癌症治疗相关皮肤反应的实际案例
errJournal of Drugs in Dermatology
IF0
err2025-12-01
err0
PREAI
errKauppi, Samsa; Bjerring, Peter; Girnita, Ada; Guenin, Sophie; Stensvold, Andreas; Lynde, Charles
err分享
err收藏
Targeting IL-22RA1 with Temtokibart: A Novel Approach in Atopic Dermatitis: Phase 2a Monotherapy Study Results靶向IL-22RA1的Temtokibart：特应性皮炎的一种新方法：2a期单药治疗研究结果
errJournal of Allergy and Clinical Immunology
IF11.2
err2025-11-11
err0
errOAAI
errDiamant Thaçi; Vivian Laquer; Charles Lynde; Adam Reich; Weily Soong; Margitta Worm; Petra Arlert; Allan Blemings; Thomas Litman; Britta C. Martel; Martin Olesen; Ole E. Sørensen; Melinda Gooderham
err分享
err收藏
362 Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)362 乌帕替尼在成人和青少年重度斑秃患者中的疗效、安全性和耐受性：来自随机、安慰剂对照、双盲III期研究（UP-AA）的结果
errJournal of Investigative Dermatology
IF5.7
err2025-11-10
err0
PREAI
errArash Mostaghimi; Melinda Gooderham; Charles Lynde; Rodney Sinclair; Brett King; Maria Hordinsky; Lidia Rudnicka; Emma Guttman-Yassky; Sebastian Meerwein; Ahmed Soliman; Xianwei Bu; Chenyang Duan; Tianshuang Wu; Henrique Teixeira; Andreas Lazar; Thierry Passeron
err分享
err收藏
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
errNEJM Evidence
IF0
err2025-11-01
err3
PREAI
errGooderham, Melinda; Lain, Edward; Bissonnette, Robert; Huang, Yu-Huei; Lynde, Charles W.; Hoffmann, Matthias; Song, Eingun James; Weirich, Oliver; Ceitlin, Raul Hernan Gabriel; Rubens, Jessica H.; Delozier, Amy M.; Ota, Takayuki; Hsu, Ming-Chun; Li, Shu; Deklotz, Cynthia M. C.; Nunes, Fabio; Warren, Richard B.
err分享
err收藏
Considerations for Treating Generalized Pustular Psoriasis (GPP): A Narrative Review治疗泛发性脓疱型银屑病（GPP）的考量：一篇叙述性综述
errDermatology and Therapy
IF4.2
err2025-10-09
err0
errOAAI
errCharles W. Lynde; Vimal H. Prajapati; Melinda J. Gooderham; H. Chih-ho Hong; Mark G. Kirchhof; Perla Lansang; Julien Ringuet; Irina Turchin; Ron Vender; Jensen Yeung; Kim A. Papp
err分享
err收藏
Current Understanding of Seborrheic Dermatitis: Presentation, Diagnosis, and Special Populations脂溢性皮炎的当前理解：临床表现、诊断及特殊人群
errJournal of Cutaneous Medicine and Surgery
IF3.9
err2025-09-18
err0
PREAI
errIrina Turchin; Lorne Albrecht; Sameh Hanna; Dimitrios Kyritsis; Wei Jing Loo; Charles W. Lynde; Vimal H. Prajapati; Kerri Purdy; Linda Rochette; Marni Wiseman; Daniel Wong; Geeta Yadav; Jensen Yeung; Melinda Gooderham
err分享
err收藏
Current Understanding of Seborrheic Dermatitis: Treatment Options脂溢性皮炎的当前认识：治疗选择
errJournal of Cutaneous Medicine and Surgery
IF3.9
err2025-09-18
err0
PREAI
errIrina Turchin; Lorne Albrecht; Sameh Hanna; Dimitrios Kyritsis; Wei Jing Loo; Charles W. Lynde; Vimal H. Prajapati; Kerri Purdy; Linda Rochette; Marni Wiseman; Daniel Wong; Geeta Yadav; Jensen Yeung; Melinda Gooderham
err分享
err收藏
Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology脂溢性皮炎的当前认识：流行病学、疾病负担和发病机制
errJournal of Cutaneous Medicine and Surgery
IF3.9
err2025-09-18
err0
PREAI
errIrina Turchin; Lorne Albrecht; Sameh Hanna; Dimitrios Kyritsis; Wei Jing Loo; Charles W. Lynde; Vimal H. Prajapati; Kerri Purdy; Linda Rochette; Marni Wiseman; Daniel Wong; Geeta Yadav; Jensen Yeung; Melinda Gooderham
err分享
err收藏
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study阿利替利单抗（Amlitelimab），一种抗OX40配体抗体，用于治疗特应性皮炎：STREAM-AD临床研究的简明语言摘要
errImmunotherapy
IF2.9
err2025-09-01
err0
errOAAI
errStephan Weidinger; Andrew Blauvelt; Kim A. Papp; Adam Reich; Chih-Hung Lee; Margitta Worm; Charles Lynde; Yoko Kataoka; Peter Foley; Xiaodan Wei; Wanling Wong; Anne-Catherine Solente; Christine Weber; Samuel Adelman; Sonya Davey; Fabrice Hurbin; Natalie Rynkiewicz; Karl Yen; John T. O’Malley; Charlotte Bernigaud
err分享
err收藏
Correction: Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry更正：在开始使用Dupilumab治疗的轻中度特应性皮炎患者中观察到完全/近乎完全的瘙痒反应：来自PROSE登记册的3年真实世界中期数据
errDermatology and Therapy
IF4.2
err2025-07-21
err0
errOAAI
errNeal Bhatia; Charles W. Lynde; Luz Fonacier; Liyang Shao; Kwinten Bosman; Andrew Korotzer
err分享
err收藏
A Canadian Real-World Study of Fixed-DOSE combination of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion for the Treatment of Moderate-to-Severe Plaque Psoriasis一项关于0.01%卤倍他索丙酸酯/0.045%他扎罗汀固定剂量组合 lotion治疗中重度斑块状银屑病的加拿大真实世界研究
errCLINICAL THERAPEUTICS
IF3.6
err2025-06-01
err0
PREAI
errVender, R.; Lynde, C.; Prajapati, V; Zeinab, R.; Legault, M.; Hong, HC-H; Barakat, M.
err分享
err收藏
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies加拿大特应性皮炎外用药物治疗管理共识指南
errDERMATOLOGY AND THERAPY
IF4.2
err2025-04-25
err0
errOAAI
errGooderham, Melinda J.; Hong, H. Chih-ho; Lynde, Charles; Papp, Kim A.; Yeung, Jensen; Lui, Harvey; Miller-Monthrope, Yvette; Ringuet, Julien; Turchin, Irina; Prajapati, Vimal H.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
Dafna D. Gladman
H 指数: 143 · 论文数: 1.6K
J
James G. Krueger
H 指数: 143 · 论文数: 747
M
Marcus Maurer
H 指数: 128 · 论文数: 1.5K
G
Giorgio Walter Canonica
H 指数: 127 · 论文数: 1.7K
J
Juliet N. Barker
H 指数: 121 · 论文数: 1.1K
查看更多